Harmony Biosciences Holdings Inc

2026. g. 11. sept. 22:56 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, remaining above its 20-day moving average and near the upper end of its one-month range.

2026. g. 9. sept. 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Wednesday's session, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

2026. g. 8. sept. 20:13 UTC

Harmony Biosciences Holdings Inc is higher in after-market trading, supported by solid performance above its 20-day moving average and nearing its one-month trading range.

2026. g. 3. sept. 20:02 UTC

Harmony Biosciences announced it will present EPX-100 data at a future congress. Shares are trading lower, reversing from an earlier session high.

2026. g. 2. sept. 20:01 UTC

Harmony Biosciences Holdings Inc is higher today, reflecting positive market response despite no specific news. Broader market context includes slower job growth reported by ADP.

2026. g. 1. sept. 23:01 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, continuing an upward trend from three consecutive sessions of gains. No specific news was identified.

2026. g. 31. aug. 22:06 UTC

Harmony Biosciences shares are higher in after-market trading, rebounding from an initial dip amid geopolitical tensions affecting broader market conditions.

2026. g. 28. aug. 20:07 UTC

Harmony Biosciences Holdings Inc shares are lower during Friday's session, continuing a decline since Thursday's close amid no specific news to explain the downturn.

2026. g. 27. aug. 19:56 UTC

Harmony Biosciences will participate in the 2026 Cantor Global Healthcare Conference. Shares are higher today, reflecting positive market sentiment since Wednesday's close.

2026. g. 26. aug. 20:08 UTC

Wolfe Research initiated coverage on Harmony Biosciences with an Outperform rating and a $60 price target, contributing to higher shares during Wednesday's session.

2026. g. 25. aug. 19:26 UTC

Shares of Harmony Biosciences Holdings Inc. are modestly higher, trading within a narrow range amid routine performance during Tuesday's session.

2026. g. 24. aug. 21:01 UTC

Harmony Biosciences Holdings Inc is trading higher in after-market hours, reflecting a broader rebound in the bond market as Treasury yields decline.

2026. g. 21. aug. 22:31 UTC

Harmony Biosciences Holdings Inc. is trading higher in after-market hours, reaching the upper end of its one-month range and above the 20-day moving average.

2026. g. 20. aug. 23:31 UTC

Harmony Biosciences Holdings Inc shares are higher in after-market trading, supported by strong momentum above the 20-day moving average and within its one-month range.

2026. g. 19. aug. 19:56 UTC

Harmony Biosciences Holdings Inc. is trading higher, reaching a session high and remaining above its 20-day moving average during Wednesday's session.

2026. g. 14. aug. 19:46 UTC

Harmony Biosciences shares are lower as the Pharmaceuticals sub-sector declines. The stock remains above its 20-day moving average, indicating some underlying strength.

2026. g. 13. aug. 22:51 UTC

Harmony Biosciences shares are rising in after-market trading, supported by favorable macroeconomic indicators and a broader trend in major averages closing higher.

2026. g. 11. aug. 19:21 UTC

Harmony Biosciences Holdings Inc. is trading higher today, continuing its upward trajectory since Monday's close amid broader market trends and rising oil prices.

2026. g. 10. aug. 19:46 UTC

Harmony Biosciences Holdings Inc is trading higher, continuing its upward trend since Friday. The stock remains above its 20-day moving average.

2026. g. 7. aug. 20:06 UTC

Shares of Harmony Biosciences Holdings Inc. are lower amid broader market declines and decreasing Treasury yields following recent economic data.

2026. g. 6. aug. 23:51 UTC

Harmony Biosciences Holdings Inc shares declined during after-market hours, struggling to maintain earlier gains amid a lack of specific news to explain the movement.

2026. g. 5. aug. 20:03 UTC

Harmony Biosciences shares are lower despite new Phase 1 data on BP-205. Truist maintains a Hold rating and raises the price target to $34.

2026. g. 4. aug. 20:04 UTC

Harmony Biosciences reported strong Q2 earnings of $75.43 million and reaffirmed 2026 revenue guidance, with shares trading sharply higher during the session.

2026. g. 3. aug. 23:11 UTC

Harmony Biosciences shares are higher in after-hours trading, supported by positive sentiment from the Institute for Supply Management's manufacturing PMI report.

2026. g. 1. aug. 00:01 UTC

Shares of Harmony Biosciences Holdings Inc are higher in after-market trading, reflecting notable strength since Friday's close without any specific news driving the move.

2026. g. 31. jūl. 23:21 UTC

Harmony Biosciences Holdings Inc. is trading higher during after-market hours, reflecting steady price increases since Friday's close, despite no specific news identified.

2026. g. 28. jūl. 18:26 UTC

Shares of Harmony Biosciences are lower despite a 30% revenue increase for WAKIX, as market sentiment reflects concerns over potential cash flow erosion.

2026. g. 27. jūl. 19:41 UTC

Shares of Harmony Biosciences Holdings Inc. are higher today, breaking from a recent upward trend despite the absence of specific company news.

2026. g. 24. jūl. 17:06 UTC

Shares of Harmony Biosciences Holdings Inc. are lower today, continuing a decline since Thursday's close, despite earlier reaching a session high.

2026. g. 22. jūl. 20:01 UTC

Harmony Biosciences Holdings Inc is trading lower despite preliminary Q2 2026 results showing record net product revenue of approximately $261 million, a 30% year-over-year increase.